Literature DB >> 17712262

Assessment of the clinical management of fragility fractures and implications for the new HEDIS osteoporosis measure.

Kathleen A Foley1, Shonda A Foster, Eric S Meadows, Onur Baser, Stacey R Long.   

Abstract

BACKGROUND: Rates of screening for and treatment of osteoporosis have been low, even among those with fractures who are at greatest risk for new fractures.
OBJECTIVE: The objective of this study was to examine trends in the clinical management of patients with fragility fractures to provide baseline data for future assessments of the impact of the new Health Plan Employer Data and Information Set (HEDIS) measure. RESEARCH
DESIGN: The MarketScan Medicare Supplemental and Coordination of Benefits (COB) database was used to examine adherence to the 2004 HEDIS guidelines by measuring the percent of women age 67 and older who were screened and/or treated after a fracture from 2000 through 2005. Clinical, demographic, and provider characteristics were assessed to determine the correlates of being screened and treated.
RESULTS: The overall unadjusted percent of women screened and treated remains low, with just 10.2% screened and 12.9% treated in 2005. Multivariate analyses, which controlled for fracture location, patient characteristics, physician specialty, and region indicated small, albeit statistically significant, increases in treatment and screening over time. Women fracturing in 2005 were 27% more likely to be screened and 15% more likely to receive treatment relative to those fracturing in the year 2000.
CONCLUSIONS: Although our study found some improvements in the screening for and treatment of osteoporosis among Medicare beneficiaries with a fragility fracture from 2000 through 2005, the overall percent of women screened and/or treated remained low. These data provide a baseline for assessing the impact of the new HEDIS measure in the coming years.

Entities:  

Mesh:

Year:  2007        PMID: 17712262     DOI: 10.1097/MLR.0b013e3180536764

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  10 in total

Review 1.  Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases.

Authors:  E Michael Lewiecki
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-04       Impact factor: 5.346

Review 2.  Sclerostin and skeletal health.

Authors:  Maryam Sharifi; Lisa Ereifej; E Michael Lewiecki
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

3.  Adverse drug interactions: moving from perception to action.

Authors:  Ryan Mayhew; June M McKoy; Thanh Ha Luu; Isaac Lopez; Melissa Frick; Charles L Bennett
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 4.  Bone mineral density testing after fragility fracture: Informative test results likely.

Authors:  Joshua Posen; Dorcas E Beaton; Joanna Sale; Earl R Bogoch
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

Review 5.  Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients.

Authors:  J E M Sale; D Beaton; J Posen; V Elliot-Gibson; E Bogoch
Journal:  Osteoporos Int       Date:  2011-05-24       Impact factor: 4.507

6.  Patients do not have a consistent understanding of high risk for future fracture: a qualitative study of patients from a post-fracture secondary prevention program.

Authors:  J E M Sale; M A Gignac; G Hawker; D Beaton; L Frankel; E Bogoch; V Elliot-Gibson
Journal:  Osteoporos Int       Date:  2015-06-27       Impact factor: 4.507

7.  The role of risk communication in the care of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Curr Osteoporos Rep       Date:  2011-09       Impact factor: 5.096

8.  Osteoporosis care at risk in the United States.

Authors:  E M Lewiecki; S Baim; E S Siris
Journal:  Osteoporos Int       Date:  2008-08-29       Impact factor: 4.507

9.  Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drug Healthc Patient Saf       Date:  2011-12-01

10.  Established Osteoporosis and Gaps in the Management: Review from a Teaching hospital.

Authors:  Mir Sadat-Ali; As Al-Omran; Wi Al-Bakr; Md Quamar Azam; Am Tantawy; Aa Al-Othman
Journal:  Ann Med Health Sci Res       Date:  2014-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.